entertainment -WSS

entertainment

author：leisure time 2025-09-28 21:05:40 - browse：78

Photo illustration of Stephen HEMSLEY -- UnitedHealth coverage from STAT — Stephen Hemsley, chair of the board and former chief executive officer of UnitedHealth Group Inc. Photo illustration: Alex Hogan; Source: AP

Stephen Hemsley, the former CEO of UnitedHealth Group and its current board chair, also owns an investment firm that manages his own portfolio of UnitedHealth stock and oversees other wealthy individuals’ accounts that have held shares of companies that have direct business with or indirect ties to United.

It’s an unusual arrangement for someone in such a prominent role at one of the largest health care corporations in the world, according to several experts in securities and corporate law interviewed by STAT, and one that they said highlights shortcomings in government disclosure requirements and raises concerns about potential conflicts of interest.

The arrangement is perfectly legal. But while other board chairs at large publicly traded health care companies, like Thomas Frist III at HCA Healthcare, hold high-ranking titles in the investment world, none were longtime chief executives of the same company they chair, like Hemsley. UnitedHealth also does not disclose Hemsley’s investment firm ownership to its shareholders in regular disclosures.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Louisiana bill approved classifying abortion pills as controlled substances

explore

hotspot

WSS

Why we need mandatory labeling of GMO products

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

New research sheds light on how often breast cancer is overdiagnosed

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Louisiana bill approved classifying abortion pills as controlled substances

Decentralized clinical trials need collaboration to achieve wider use

explore

entertainment

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Should insurance cover cosmetic surgery?

Walensky prepares to leave CDC — and Congress — behind

Beyond aggravation: Constipation is an American epidemic

As demand for Covid shots wanes, Moderna seeks its next success

New research sheds light on how often breast cancer is overdiagnosed

Sports medicine is finally prioritizing gender equality

Achieving telehealth equity for people with hearing loss

How one medical school became remarkably diverse

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

explore

The Bio Revolution is changing business and society

Pharma’s losing bet in New Jersey

Unmasking the 'centricity' illusion in clinical trials

Decentralized clinical trials need collaboration to achieve wider use

Hospitals need to get ahead of regulations on climate change

Pharma’s losing bet in New Jersey

explore

leisure time

hotspot

knowledge